Stay updated on Emicizumab Prophylaxis in Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Emicizumab Prophylaxis in Hemophilia A Clinical Trial page.

Latest updates to the Emicizumab Prophylaxis in Hemophilia A Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded a comprehensive Locations section with trial sites by region (e.g., California, DC, Florida, Georgia, Massachusetts, Michigan, New York, Washington; South Australia, Victoria, Western Australia; Lombardy, Tuscany) and updated to Revision: v3.3.3; existing location entries were reorganized/removed.SummaryDifference1.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2; no other study content or navigation items appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedPublications section now states that entries are automatically filled from PubMed and includes the Revision: v3.3.1 tag, a minor wording change that does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedThe funding-status banner was removed from the page. The core trial information (title, NCT number, locations, eligibility criteria, and outcomes) remains unchanged.SummaryDifference0.2%

- Check65 days agoChange DetectedNo significant changes detected between the old and new screenshots; the page content and structure appear unchanged.SummaryDifference0.3%

- Check94 days agoChange DetectedMajor change: the page now includes an operating-status notice and a new version label (v3.2.0) while removing the old version tag (v3.1.0).SummaryDifference0.9%

Stay in the know with updates to Emicizumab Prophylaxis in Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emicizumab Prophylaxis in Hemophilia A Clinical Trial page.